How Do You Spell MYELOGENIC SARCOMA?

Pronunciation: [mˌa͡ɪɪlə͡ʊd͡ʒˈɛnɪk sɑːkˈə͡ʊmə] (IPA)

Myelogenic sarcoma is a type of cancer that affects the bone marrow. The word is spelled using the International Phonetic Alphabet (IPA) as /maɪələˈdʒɛnɪk sɑrkˈoʊmə/. The word is made up of two parts, "myelo" which refers to the bone marrow and "genic" which means producing or forming. The second part of the word, "sarcoma," refers to a type of cancer that develops in the connective tissues such as bones, cartilage or muscles. Therefore, "myelogenic sarcoma" refers to a cancerous mass or tumor that originates in the bone marrow.

MYELOGENIC SARCOMA Meaning and Definition

1. Myelogenic sarcoma is a rare type of cancerous tumor that arises from cells of the bone marrow. It is also known as chloroma or granulocytic sarcoma, referring to its greenish appearance due to a high concentration of myeloperoxidase-positive (MPO) immature myeloid cells.

   The tumor primarily affects individuals with acute myeloid leukemia (AML) or other myeloproliferative disorders. It can occur in various parts of the body, including bones, soft tissues, lymph nodes, skin, and even organs such as the liver or spleen. Myelogenic sarcoma is often characterized by its rapid growth and infiltration into surrounding healthy tissues.

   Symptoms of myelogenic sarcoma vary depending on the location of the tumor. Common manifestations may include localized pain, swelling, or a palpable mass. In some cases, patients may experience systemic symptoms like fever, fatigue, weight loss, or night sweats. Diagnosing myelogenic sarcoma typically involves imaging tests like X-rays, CT scans, or MRI scans, complemented by a biopsy for confirmation.

   Treatment options for myelogenic sarcoma usually involve a combination of chemotherapy, radiation therapy, and sometimes surgical removal of the tumor. The choice of treatment depends on factors such as the size and extent of the tumor, as well as the presence of any underlying blood disorders. Prognosis varies from case to case, but early diagnosis followed by aggressive therapy has shown better outcomes. However, the overall prognosis for myelogenic sarcoma remains generally poor due to its association with underlying hematological malignancies.

2. One originating in the bone-marrow.

   A practical medical dictionary. By Stedman, Thomas Lathrop. Published 1920.

Common Misspellings for MYELOGENIC SARCOMA

• nyelogenic sarcoma
• kyelogenic sarcoma
• jyelogenic sarcoma
• mtelogenic sarcoma
• mgelogenic sarcoma
• mhelogenic sarcoma
• muelogenic sarcoma
• m7elogenic sarcoma
• m6elogenic sarcoma
• mywlogenic sarcoma
• myslogenic sarcoma
• mydlogenic sarcoma
• myrlogenic sarcoma
• my4logenic sarcoma
• my3logenic sarcoma
• myekogenic sarcoma
• myepogenic sarcoma
• myeoogenic sarcoma
• myeligenic sarcoma
• myelkgenic sarcoma

Etymology of MYELOGENIC SARCOMA

The word "myelogenic sarcoma" is composed of two parts:

1. Myelogenic: The term "myelogenic" is derived from two Greek roots: "myelo-" derived from "myelos" meaning marrow or spinal cord, and "-genic" derived from "genus" meaning born or produced. In medical terminology, "myelogenic" refers to something relating to or originating from the marrow or spinal cord.

2. Sarcoma: The term "sarcoma" is derived from the Greek word "sarkoma", meaning fleshy excrescence. It refers to a type of cancerous tumor that arises from connective tissues, such as bones, cartilage, or muscle.

Combining these two components, "myelogenic sarcoma" refers to a cancerous tumor that originates from the marrow or spinal cord, primarily affecting connective tissues.